Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype.

Neurology - 27 Oct 2020

Babapour Mofrad Rosha, Tijms Betty M, Scheltens Philip, Barkhof Frederik, van der Flier Wiesje M, Sikkes Sietske A M, Teunissen Charlotte E

Abstract excerpt

OBJECTIVE: To evaluate sex differences in CSF biomarkers, taking the potential modifying role of clinical disease stage and APOE ε4 genotype into account. METHOD: We included participants (n = 1,801) with probable Alzheimer disease (AD) dementia (n = 937), mild cognitive impairment (MCI; n = 437), and subjective cognitive decline (SCD; n = 427). Main outcomes were CSF β-amyloid1-42 (Aβ42), total tau (t-Tau), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein E4

Share to Cognitive Dysfunction

Share to Magnetic Resonance Imaging

Share to Peptide Fragments

Share to Sex Characteristics

Share to tau Proteins

Source

Identifiers

PMID: 32788242
DOI: 10.1212/WNL.0000000000010629

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype.PMID 32788242Read ↗

Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.Semantic proximity Read ↗

Sex Differences in Apolipoprotein E and Alzheimer Disease Pathology Across AncestriesSemantic proximity Read ↗

APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.Semantic proximity Read ↗

Sex Differences in the Relationship of Biomarker Change to Memory Decline in Early Alzheimer’s Disease: an Observational Cohort StudySemantic proximity Read ↗

Sex influences the effects of APOE genotype and Alzheimer’s diagnosis on neuropathology and memorySemantic proximity Read ↗

Sex influences the effects of APOE genotype and Alzheimer's diagnosis on neuropathology and memory.Semantic proximity Read ↗

Sex modifies the APOE-related risk of developing Alzheimer disease.Semantic proximity Read ↗

Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer DiseaseSemantic proximity Read ↗

Differential Associations of APOEɛ2 and APOEɛ4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia.Semantic proximity Read ↗

CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.Semantic proximity Read ↗

Association of plasma phosphor-tau181 with Aβ levels may vary by APOE ε4 status and sex among non-demented old adults.Semantic proximity Read ↗

Sex differences in the association between apolipoprotein E ε4 allele and Alzheimer's disease markersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.